tetralol

Known as: 1,2,3,4-tetrahydro-2-naphthol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1945-2018
024619452017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Three new tetralol analogs, myrochromanols A-C (1-3), together with 11 known trichothecenes (4-14), were isolated from a soil… (More)
Is this relevant?
2006
2006
Mibefradil is a tetralol derivative once marketed to treat hyper-tension. Its primary target is the T-type Ca(2+) channel (IC(50… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2006
2006
Mibefradil is a tetralol derivative once marketed to treat hypertension. Its primary target is the T-type Ca channel (IC50, 0.1–0… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2005
2005
Steady-state radiolysis experiments were performed to investigate the mechanisms of the radiolytic degradation of Acid Orange 7… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Mibefradil is a tetralol derivative chemically distinct from other calcium channel antagonists. It is a very effective… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?
1998
1998
Mibefradil is a single-enantiomer calcium antagonist belonging to a new class, the tetralol derivatives. The recommended doses… (More)
Is this relevant?
1998
1998
BACKGROUND Mibefradil, a newly approved antihypertensive and antianginal drug, is the first member of a new class of calcium… (More)
Is this relevant?
1998
1998
Mibefradil is the first of a new class of calcium antagonists (CAs), the tetralol derivatives, that selectively blocks the T-type… (More)
Is this relevant?
1997
1997
Mibefradil is a novel Ca2+ antagonist acting on both L- and T-type Ca2+ channels, with a ten-fold selectivity for T-type Ca2… (More)
Is this relevant?